Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature
Identifieur interne : 007059 ( Main/Exploration ); précédent : 007058; suivant : 007060Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature
Auteurs : Shona Wynd [Royaume-Uni, Australie] ; Wayne D. Melrose [Australie] ; David N. Durrheim [Australie] ; Jaime Carron [Canada] ; Margaret Gyapong [Ghana]Source :
- Bulletin of the World Health Organization [ 0042-9686 ] ; 2007.
Descripteurs français
- KwdFr :
- Albendazole (usage thérapeutique), Association de médicaments, Caractéristiques culturelles, Connaissances, attitudes et pratiques en santé, Diéthylcarbamazine (usage thérapeutique), Filaricides (administration et posologie), Filaricides (usage thérapeutique), Filariose lymphatique (psychologie), Filariose lymphatique (traitement médicamenteux), Humains, Ivermectine (usage thérapeutique), Mode de vie, Prejugé, Services de santé communautaires (organisation et administration).
- MESH :
- administration et posologie : Filaricides.
- organisation et administration : Services de santé communautaires.
- psychologie : Filariose lymphatique.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Albendazole, Diéthylcarbamazine, Filaricides, Ivermectine.
- Association de médicaments, Caractéristiques culturelles, Connaissances, attitudes et pratiques en santé, Humains, Mode de vie, Prejugé.
English descriptors
- KwdEn :
- Albendazole (therapeutic use), Community Health Services (organization & administration), Cultural Characteristics, Diethylcarbamazine (therapeutic use), Drug Therapy, Combination, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (psychology), Filaricides (administration & dosage), Filaricides (therapeutic use), Health Knowledge, Attitudes, Practice, Humans, Ivermectin (therapeutic use), Life Style, Prejudice.
- MESH :
- chemical , administration & dosage : Filaricides.
- chemical , therapeutic use : Albendazole, Diethylcarbamazine, Filaricides, Ivermectin.
- drug therapy : Elephantiasis, Filarial.
- organization & administration : Community Health Services.
- psychology : Elephantiasis, Filarial.
- Cultural Characteristics, Drug Therapy, Combination, Health Knowledge, Attitudes, Practice, Humans, Life Style, Prejudice.
Abstract
Lymphatic filariasis (LF) is endemic in approximately 80 tropical and subtropical countries. About 120 million people are infected with the parasite and a billion are estimated to be at risk of infection. The main focus of the LF elimination programme to date has been to interrupt transmission by means of annual community-wide treatment campaigns with diethylcarbamazine and albendazole, or albendazole and ivermectin, for a period of four to six years. Although substantial progress has been recorded wherever the strategy has been successfully implemented, initial gains have been accompanied by a realization that this strategy alone will not ensure a permanent solution in all settings. The fairly extensive LF literature is dominated by laboratory research and quantitative field measurement of the impact of LF, particularly local prevalence studies of parasite-infected humans and vectors. As the global elimination programme expands, the absence of sociocultural understanding is being recognized as a critical flaw in ensuring that programmes are appropriate and responsive to local needs and understanding. This paper assesses the current state of sociocultural understanding pertaining to LF. It concludes that, at present, there is insufficient understanding of the sociocultural factors associated with the presence and treatment of the disease, and that appropriate social science methods should be used to address this deficiency and ensure community partnership in delivering and sustaining the success of LF elimination programmes.
Url:
DOI: 10.2471/BLT.06.031047
PubMed: 17639248
PubMed Central: 2636343
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 004716
- to stream Pmc, to step Curation: 004715
- to stream Pmc, to step Checkpoint: 003A53
- to stream PubMed, to step Corpus: 003589
- to stream PubMed, to step Curation: 003589
- to stream PubMed, to step Checkpoint: 003589
- to stream Ncbi, to step Merge: 002807
- to stream Ncbi, to step Curation: 002807
- to stream Ncbi, to step Checkpoint: 002807
- to stream Main, to step Merge: 007179
- to stream Main, to step Curation: 007059
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature</title><author><name sortKey="Wynd, Shona" sort="Wynd, Shona" uniqKey="Wynd S" first="Shona" last="Wynd">Shona Wynd</name><affiliation wicri:level="1"><nlm:aff id="aff1">Department for International Development, East Kilbride, United Kingdom.</nlm:aff><country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country><wicri:regionArea>Department for International Development, East Kilbride</wicri:regionArea><wicri:noRegion>East Kilbride</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:aff id="aff2">World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland, Australia.</nlm:aff><country xml:lang="fr" wicri:curation="lc">Australie</country><wicri:regionArea>World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Melrose, Wayne D" sort="Melrose, Wayne D" uniqKey="Melrose W" first="Wayne D" last="Melrose">Wayne D. Melrose</name><affiliation wicri:level="1"><nlm:aff id="aff2">World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland, Australia.</nlm:aff><country xml:lang="fr" wicri:curation="lc">Australie</country><wicri:regionArea>World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Durrheim, David N" sort="Durrheim, David N" uniqKey="Durrheim D" first="David N" last="Durrheim">David N. Durrheim</name><affiliation wicri:level="1"><nlm:aff id="aff2">World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland, Australia.</nlm:aff><country xml:lang="fr" wicri:curation="lc">Australie</country><wicri:regionArea>World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:aff id="aff3">Population Health, Hunter New England Health, Wallsend, 2287, New South Wales, Australia.</nlm:aff><country xml:lang="fr" wicri:curation="lc">Australie</country><wicri:regionArea>Population Health, Hunter New England Health, Wallsend, 2287, New South Wales</wicri:regionArea><wicri:noRegion>New South Wales</wicri:noRegion></affiliation></author><author><name sortKey="Carron, Jaime" sort="Carron, Jaime" uniqKey="Carron J" first="Jaime" last="Carron">Jaime Carron</name><affiliation wicri:level="1"><nlm:aff id="aff4">60 Holgate St., Barrie, Ontario, Canada.</nlm:aff><country xml:lang="fr" wicri:curation="lc">Canada</country><wicri:regionArea>60 Holgate St., Barrie, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Gyapong, Margaret" sort="Gyapong, Margaret" uniqKey="Gyapong M" first="Margaret" last="Gyapong">Margaret Gyapong</name><affiliation wicri:level="1"><nlm:aff id="aff5">Dodowa Health Research Centre, Dodowa, Ghana.</nlm:aff><country xml:lang="fr" wicri:curation="lc">Ghana</country><wicri:regionArea>Dodowa Health Research Centre, Dodowa</wicri:regionArea><wicri:noRegion>Dodowa</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">17639248</idno><idno type="pmc">2636343</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636343</idno><idno type="RBID">PMC:2636343</idno><idno type="doi">10.2471/BLT.06.031047</idno><date when="2007">2007</date><idno type="wicri:Area/Pmc/Corpus">004716</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">004716</idno><idno type="wicri:Area/Pmc/Curation">004715</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">004715</idno><idno type="wicri:Area/Pmc/Checkpoint">003A53</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003A53</idno><idno type="wicri:source">PubMed</idno><idno type="wicri:Area/PubMed/Corpus">003589</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003589</idno><idno type="wicri:Area/PubMed/Curation">003589</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003589</idno><idno type="wicri:Area/PubMed/Checkpoint">003589</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003589</idno><idno type="wicri:Area/Ncbi/Merge">002807</idno><idno type="wicri:Area/Ncbi/Curation">002807</idno><idno type="wicri:Area/Ncbi/Checkpoint">002807</idno><idno type="wicri:doubleKey">0042-9686:2007:Wynd S:understanding:the:community</idno><idno type="wicri:Area/Main/Merge">007179</idno><idno type="wicri:Area/Main/Curation">007059</idno><idno type="wicri:Area/Main/Exploration">007059</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature</title><author><name sortKey="Wynd, Shona" sort="Wynd, Shona" uniqKey="Wynd S" first="Shona" last="Wynd">Shona Wynd</name><affiliation wicri:level="1"><nlm:aff id="aff1">Department for International Development, East Kilbride, United Kingdom.</nlm:aff><country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country><wicri:regionArea>Department for International Development, East Kilbride</wicri:regionArea><wicri:noRegion>East Kilbride</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:aff id="aff2">World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland, Australia.</nlm:aff><country xml:lang="fr" wicri:curation="lc">Australie</country><wicri:regionArea>World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Melrose, Wayne D" sort="Melrose, Wayne D" uniqKey="Melrose W" first="Wayne D" last="Melrose">Wayne D. Melrose</name><affiliation wicri:level="1"><nlm:aff id="aff2">World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland, Australia.</nlm:aff><country xml:lang="fr" wicri:curation="lc">Australie</country><wicri:regionArea>World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Durrheim, David N" sort="Durrheim, David N" uniqKey="Durrheim D" first="David N" last="Durrheim">David N. Durrheim</name><affiliation wicri:level="1"><nlm:aff id="aff2">World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland, Australia.</nlm:aff><country xml:lang="fr" wicri:curation="lc">Australie</country><wicri:regionArea>World Health Organization Collaborating Centre for Lymphatic Filariasis, School of Public Health and Tropical Medicine, James Cook University, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation><affiliation wicri:level="1"><nlm:aff id="aff3">Population Health, Hunter New England Health, Wallsend, 2287, New South Wales, Australia.</nlm:aff><country xml:lang="fr" wicri:curation="lc">Australie</country><wicri:regionArea>Population Health, Hunter New England Health, Wallsend, 2287, New South Wales</wicri:regionArea><wicri:noRegion>New South Wales</wicri:noRegion></affiliation></author><author><name sortKey="Carron, Jaime" sort="Carron, Jaime" uniqKey="Carron J" first="Jaime" last="Carron">Jaime Carron</name><affiliation wicri:level="1"><nlm:aff id="aff4">60 Holgate St., Barrie, Ontario, Canada.</nlm:aff><country xml:lang="fr" wicri:curation="lc">Canada</country><wicri:regionArea>60 Holgate St., Barrie, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Gyapong, Margaret" sort="Gyapong, Margaret" uniqKey="Gyapong M" first="Margaret" last="Gyapong">Margaret Gyapong</name><affiliation wicri:level="1"><nlm:aff id="aff5">Dodowa Health Research Centre, Dodowa, Ghana.</nlm:aff><country xml:lang="fr" wicri:curation="lc">Ghana</country><wicri:regionArea>Dodowa Health Research Centre, Dodowa</wicri:regionArea><wicri:noRegion>Dodowa</wicri:noRegion></affiliation></author></analytic><series><title level="j">Bulletin of the World Health Organization</title><idno type="ISSN">0042-9686</idno><imprint><date when="2007">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Albendazole (therapeutic use)</term><term>Community Health Services (organization & administration)</term><term>Cultural Characteristics</term><term>Diethylcarbamazine (therapeutic use)</term><term>Drug Therapy, Combination</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (psychology)</term><term>Filaricides (administration & dosage)</term><term>Filaricides (therapeutic use)</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Ivermectin (therapeutic use)</term><term>Life Style</term><term>Prejudice</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Albendazole (usage thérapeutique)</term><term>Association de médicaments</term><term>Caractéristiques culturelles</term><term>Connaissances, attitudes et pratiques en santé</term><term>Diéthylcarbamazine (usage thérapeutique)</term><term>Filaricides (administration et posologie)</term><term>Filaricides (usage thérapeutique)</term><term>Filariose lymphatique (psychologie)</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Humains</term><term>Ivermectine (usage thérapeutique)</term><term>Mode de vie</term><term>Prejugé</term><term>Services de santé communautaires (organisation et administration)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Filaricides</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term><term>Diethylcarbamazine</term><term>Filaricides</term><term>Ivermectin</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Services de santé communautaires</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Community Health Services</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term><term>Diéthylcarbamazine</term><term>Filaricides</term><term>Ivermectine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Cultural Characteristics</term><term>Drug Therapy, Combination</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Life Style</term><term>Prejudice</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association de médicaments</term><term>Caractéristiques culturelles</term><term>Connaissances, attitudes et pratiques en santé</term><term>Humains</term><term>Mode de vie</term><term>Prejugé</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><title>Abstract</title><p>Lymphatic filariasis (LF) is endemic in approximately 80 tropical and subtropical countries. About 120 million people are infected with the parasite and a billion are estimated to be at risk of infection. The main focus of the LF elimination programme to date has been to interrupt transmission by means of annual community-wide treatment campaigns with diethylcarbamazine and albendazole, or albendazole and ivermectin, for a period of four to six years. Although substantial progress has been recorded wherever the strategy has been successfully implemented, initial gains have been accompanied by a realization that this strategy alone will not ensure a permanent solution in all settings. The fairly extensive LF literature is dominated by laboratory research and quantitative field measurement of the impact of LF, particularly local prevalence studies of parasite-infected humans and vectors. As the global elimination programme expands, the absence of sociocultural understanding is being recognized as a critical flaw in ensuring that programmes are appropriate and responsive to local needs and understanding. This paper assesses the current state of sociocultural understanding pertaining to LF. It concludes that, at present, there is insufficient understanding of the sociocultural factors associated with the presence and treatment of the disease, and that appropriate social science methods should be used to address this deficiency and ensure community partnership in delivering and sustaining the success of LF elimination programmes.</p></div></front></TEI><affiliations><list><country><li>Australie</li><li>Canada</li><li>Ghana</li><li>Royaume-Uni</li></country></list><tree><country name="Royaume-Uni"><noRegion><name sortKey="Wynd, Shona" sort="Wynd, Shona" uniqKey="Wynd S" first="Shona" last="Wynd">Shona Wynd</name></noRegion></country><country name="Australie"><noRegion><name sortKey="Wynd, Shona" sort="Wynd, Shona" uniqKey="Wynd S" first="Shona" last="Wynd">Shona Wynd</name></noRegion><name sortKey="Durrheim, David N" sort="Durrheim, David N" uniqKey="Durrheim D" first="David N" last="Durrheim">David N. Durrheim</name><name sortKey="Durrheim, David N" sort="Durrheim, David N" uniqKey="Durrheim D" first="David N" last="Durrheim">David N. Durrheim</name><name sortKey="Melrose, Wayne D" sort="Melrose, Wayne D" uniqKey="Melrose W" first="Wayne D" last="Melrose">Wayne D. Melrose</name></country><country name="Canada"><noRegion><name sortKey="Carron, Jaime" sort="Carron, Jaime" uniqKey="Carron J" first="Jaime" last="Carron">Jaime Carron</name></noRegion></country><country name="Ghana"><noRegion><name sortKey="Gyapong, Margaret" sort="Gyapong, Margaret" uniqKey="Gyapong M" first="Margaret" last="Gyapong">Margaret Gyapong</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007059 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 007059 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:2636343
|texte= Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:17639248" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |